DCT
1:14-cv-00664
AstraZeneca Ab v. Aurobindo Pharma Ltd
General
Filed
05/23/14
Cause of ActionPatent Infringement
SectorBiotech
Status
Closed (02/02/17)
Patent Owner
Operating Company (W)
PACER1:14-cv-00664
CourtD. Delaware
Judge | Period | PO Win Rate |
|---|---|---|
-- | 45% |
Plaintiff
Party
Name | Ratings |
|---|---|
L5A |
Attorney
Name | Ratings |
|---|---|
L5A | |
L5A | |
L5B | |
L5D | |
L4B | |
L3B | |
L3-- -- | |
L2A | |
L4A | |
L4A | |
L4A | |
L4B | |
L4C | |
L3A | |
L3B | |
---- -- |
Defendant
Party
Name | Ratings |
|---|---|
L3E | |
L5E | |
L5E | |
L5E | |
L5E | |
L5E | |
L5E | |
L5E | |
L5E | |
L5E | |
L4E | |
L4E | |
L4E | |
L4E | |
L3E | |
L3E | |
L3E | |
L3E | |
L3E |
Attorney
Name | Ratings |
|---|---|
L5A | |
L5A | |
L5A | |
L4C | |
L2E | |
L5B | |
L4E | |
L3B | |
L2E | |
L1D | |
L5B | |
L5E | |
L5E | |
L5E | |
L5E | |
L4C | |
L2D | |
L5B | |
L4E | |
L4E | |
L3E | |
L4B | |
L5A | |
L5E | |
L4A | |
L4E | |
L4B | |
L3B | |
L2B | |
L4C | |
L4E | |
L3E | |
L4C | |
L2D | |
L2E | |
L4D | |
L5E | |
L5E | |
L5E | |
L5E | |
L5E | |
L4A | |
L4D | |
L4E | |
L4E | |
L3E | |
L2C | |
L4D | |
L4D | |
L2E | |
Morris James LLPLocal | L4E |
L3E | |
L1-- -- | |
L3B | |
L5A | |
L4B | |
L4D | |
L3B | |
L3B | |
L3C | |
L4E | |
Shaw Keller LLPLocal | L3C |
L4B | |
L4E | |
L1C | |
Proctor Heyman LLPLocal | L3E |
L2E | |
L3E | |
L4E | |
L4E | |
L2E | |
L3E | |
L1B | |
L2C | |
L5D |